Actively Recruiting

Age: 18Years +
FEMALE
NCT07041606

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Led by AstraZeneca · Updated on 2026-02-24

500

Participants Needed

21

Research Sites

105 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Multicenter, observational, prospective study of molecular profiling in advanced and aggressive endometrial cancer patients and 1-st line treatment approaches in Russian Federation

CONDITIONS

Official Title

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients aged 18 years or older
  • Signed informed consent including agreement for tumor tissue testing
  • Newly diagnosed, histologically confirmed advanced (stage III-IV) endometrial cancer within 4 months
  • Endometrioid grade 3 or any non-endometrioid histological subtype of endometrial cancer
  • Availability of biopsy or postoperative archival tumor tissue sample
  • Availability of source medical records
Not Eligible

You will not qualify if you...

  • Participation in interventional clinical studies since diagnosis of advanced endometrial cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

Research Site

Arkhangelsk, Russia

Actively Recruiting

2

Research Site

Barnaul, Russia

Actively Recruiting

3

Research Site

Chelyabinsk, Russia

Actively Recruiting

4

Research Site

Irkutsk, Russia

Not Yet Recruiting

5

Research Site

Izhevsk, Russia

Actively Recruiting

6

Research Site

Krasnodar, Russia

Actively Recruiting

7

Research Site

Krasnoyarsk, Russia

Actively Recruiting

8

Research Site

Lyubertsy, Russia

Not Yet Recruiting

9

Research Site

Moscow, Russia

Actively Recruiting

10

Research Site

Moscow, Russia

Not Yet Recruiting

11

Research Site

Murmansk, Russia

Not Yet Recruiting

12

Research Site

Obninsk, Russia

Not Yet Recruiting

13

Research Site

Saint Petersburg, Russia

Actively Recruiting

14

Research Site

Saint Petersburg, Russia

Not Yet Recruiting

15

Research Site

Severodvinsk, Russia

Not Yet Recruiting

16

Research Site

Sochi, Russia

Actively Recruiting

17

Research Site

Tomsk, Russia

Actively Recruiting

18

Research Site

Tver', Russia

Actively Recruiting

19

Research Site

Ufa, Russia

Actively Recruiting

20

Research Site

Yaroslavl, Russia

Actively Recruiting

21

Research Site

Yekaterinburg, Russia

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here